242 filings
Page 2 of 13
8-K/A
yxouu33
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
8-K
j8aq xwh9yn370
6 Sep 23
Other Events
4:05pm
8-K
g276gd3d6
17 Aug 23
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma
4:15pm
8-K
rxz46 xhpyj1
14 Aug 23
EIP Pharma Announces First Patient Dosed in RewinD-LB Phase 2b Clinical Trial Evaluating Neflamapimod in Dementia with Lewy Bodies
4:15pm
8-K
obap w0lepju
9 Aug 23
Other Events
4:02pm
8-K
mlzhga81wo ib6u
3 Aug 23
Other Events
4:15pm
8-K
uv371ta69affhx53t
3 Aug 23
EIP Pharma to Present at Canaccord Genuity 43rd Annual Growth Conference
8:32am
8-K
re2ge2uu tj
31 Jul 23
Entry into a Material Definitive Agreement
5:19pm
8-K
aulxv7ue1tg6c qa7r
21 Jun 23
Departure of Directors or Certain Officers
4:05pm
8-K
iyzrju ekkti2k
19 May 23
Entry into a Material Definitive Agreement
4:31pm
8-K
eh592436is425ta
15 May 23
Other Events
5:06pm
8-K
ttqpyris9hy 0o592
11 May 23
EIP Pharma to Present at JMP Securities Life Sciences Conference
5:04pm
8-K
02aymx ocj
30 Mar 23
Form of Parent Stockholder Support Agreement
8:50am
8-K
d30 2b65lnv
16 Feb 23
Termination of a Material Definitive Agreement
4:56pm
8-K
qqlug
30 Dec 22
Submission of Matters to a Vote of Security Holders
4:27pm
8-K
h7jyorcsmq10
16 Dec 22
Diffusion Pharmaceuticals Announces Agreement with LifeSci Special Opportunities
5:10pm
8-K
ry5op zqdvgmm
5 Dec 22
Diffusion has a highly engaged and independent board that possesses the right skills and experience to execute the strategic review process
9:58pm
8-K
zi8r42
1 Dec 22
Other Events
4:34pm
8-K
ejqm rf1f973rm69xpc8
18 Nov 22
Diffusion Pharmaceuticals Sees Significant Progress in its Strategic Review Process
4:40pm
8-K
zfbihmd 65fz73xr76
14 Nov 22
Diffusion Pharmaceuticals Sees Significant Progress in its Strategic Review Process
7:40am